This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of sequencing technology and associated services to support research initiatives. The $20,210 firm fixed price purchase order, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh, does not have a set-aside designation. Oxford Nanopore Technologies holds additional federal contract vehicles, including a $300,000 blanket purchase...
This federal contract award is for the procurement of lab instrument software from Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $12,500 firm-fixed-price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a completion date of August 31, 2024. Oxford Nanopore Technologies is a provider of next-generation genomic sequencing equipment, consumables, and associated services to various...
This firm fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a subsidiary of Oxford Nanopore Technologies PLC, to provide lab equipment. The contract, which has a potential value of $106,097.00, does not have a set-aside designation and was awarded on August 27, 2021, with a completion date of September 30, 2021. Based on Oxford Nanopore Technologies' prior federal contract...
This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $43,168.00, is for the delivery of a TEC-REAGENT KIT and has a completion date of September 15, 2022. Oxford Nanopore Technologies Inc. is a leading provider of nanopore-based sequencing equipment, consumables, and associated services to federal...
This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
This is a $41,180 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the acquisition of MinION MK1C basic starter packs on behalf of the CDC's operations in Thailand. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for DNA, RNA, and protein analysis, and has secured numerous prime federal contracts from...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Oxford Nanopore Technologies Inc. to provide genomic sequencing equipment, consumables, and services. The $16,300.00 contract, which has no set-aside designation, was awarded on July 9, 2019 with a completion date of May 15, 2023. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit organization that develops nanopore-based electronic...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...